The reported statements, read against the company's own industry.
Financials view
Market Capitalization
477.61MUSD
vs all stocks (USD)
Updated Oct 27, 2026
Revenue (TTM)
221.55MUSD
vs all stocks (USD)
Updated Oct 27, 2026
Profit Margin
-3.06%
vs Medical Devices peers
Updated Oct 27, 2026
Beta
1.83x
vs all stocks
Updated Oct 27, 2026
52-Week Change
58.00%
vs all stocks
Updated Oct 27, 2026
Forward Annual Dividend Yield
0.00%
vs all stocks
Updated Oct 27, 2026
Market Capitalization
477.61MUSD
vs all stocks (USD)
Updated Oct 27, 2026
Enterprise Value
490.78MUSD
vs all stocks (USD)
Updated Oct 27, 2026
Forward P/E
-466.00x
vs Medical Devices peers
Updated Oct 27, 2026
Price to Sales (TTM)
2.12x
vs Medical Devices peers
Updated Oct 27, 2026
Price to Book (MRQ)
6.70x
vs Medical Devices peers
Updated Oct 27, 2026
Enterprise to Revenue
2.21x
vs Medical Devices peers
Updated Oct 27, 2026
Gross Margin
51.41%
vs Medical Devices peers
Updated Oct 27, 2026
Profit Margin
-3.06%
vs Medical Devices peers
Updated Oct 27, 2026
Operating Margin
-3.23%
vs Medical Devices peers
Updated Oct 27, 2026
Return on Assets (TTM)
-0.48%
vs Medical Devices peers
Updated Oct 27, 2026
Return on Equity (TTM)
-10.77%
vs Medical Devices peers
Updated Oct 27, 2026
Revenue (TTM)
221.55MUSD
vs all stocks (USD)
Updated Oct 27, 2026
Revenue per Share (TTM)
1.14USDUpdated Oct 27, 2026
Quarterly Revenue Growth
9.50%
vs Medical Devices peers
Updated Oct 27, 2026
Gross Profit (TTM)
115.31MUSD
vs all stocks (USD)
Updated Oct 27, 2026
EBITDA (TTM)
66.00KUSD
vs all stocks (USD)
Updated Oct 27, 2026
Net Income (TTM)
-6.78MUSD
vs all stocks (USD)
Updated Oct 27, 2026
Quarterly Earnings Growth (YoY)
9.53%
vs Medical Devices peers
Updated Oct 27, 2026
Operating Cash Flow (TTM)
2.42MUSD
vs all stocks (USD)
Updated Oct 27, 2026
Levered Free Cash Flow (TTM)
875.25KUSD
vs all stocks (USD)
Updated Oct 27, 2026
Forward Annual Dividend Yield
0.00%
vs all stocks
Updated Oct 27, 2026
Trailing Annual Dividend Rate
0.00USDUpdated Oct 27, 2026
Trailing Annual Dividend Yield
0.00%
vs all stocks
Updated Oct 27, 2026
Payout Ratio
0.00%
vs Medical Devices peers
Updated Oct 27, 2026
Minority Interest (Equity)
741.00KUSDFY2025 · Dec 31, 2025
Revenue
206.13MUSDFY2025 · Dec 31, 2025
Cost of Goods Sold
93.84MUSDFY2025 · Dec 31, 2025
Gross Profit
112.29MUSDFY2025 · Dec 31, 2025
Operating Income
-8.68MUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-15.28MUSDFY2025 · Dec 31, 2025
Income Tax Expense
354.00KUSDFY2025 · Dec 31, 2025
Net Income
-15.64MUSDFY2025 · Dec 31, 2025
EBIT
-6.94MUSDFY2025 · Dec 31, 2025
EBITDA (Income Statement)
-4.24MUSDFY2025 · Dec 31, 2025
Research & Development
67.72MUSDFY2025 · Dec 31, 2025
Selling, General & Administrative
80.91MUSDFY2025 · Dec 31, 2025
Other Operating Expenses
-27.66MUSDFY2025 · Dec 31, 2025
Non-operating Interest Expense
8.34MUSDFY2025 · Dec 31, 2025
EPS (Basic)
-0.0800USDFY2025 · Dec 31, 2025
EPS (Diluted)
-0.0800USDFY2025 · Dec 31, 2025
Basic Shares Outstanding
190.59MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
190.59MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
-15.64MUSDFY2025 · Dec 31, 2025
Minority Interests (P&L)
10.00KUSDFY2025 · Dec 31, 2025
Operating Cash Flow
2.11MUSDFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
20.60MUSDFY2025 · Dec 31, 2025
Income Tax Paid
301.00KUSDFY2025 · Dec 31, 2025
Interest Paid
8.52MUSDFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-15.64MUSDFY2025 · Dec 31, 2025
Depreciation & Amortization
1.43MUSDFY2025 · Dec 31, 2025
Stock-based Compensation
22.87MUSDFY2025 · Dec 31, 2025
Other Non-cash Items
2.93MUSDFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-396.00KUSDFY2025 · Dec 31, 2025
Change in Accounts Payable (CF)
5.72MUSDFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-14.81MUSDFY2025 · Dec 31, 2025
Purchase of Investments
-42.78MUSDFY2025 · Dec 31, 2025
Sale of Investments
40.34MUSDFY2025 · Dec 31, 2025
Net Investing Cash Flow
-2.44MUSDFY2025 · Dec 31, 2025
Long-term Debt Issuance
0.00USDFY2025 · Dec 31, 2025
Long-term Debt Payments
-329.00KUSDFY2025 · Dec 31, 2025
Other Financing Charges
-35.00KUSDFY2025 · Dec 31, 2025
Net Financing Cash Flow
-364.00KUSDFY2025 · Dec 31, 2025
Shares Outstanding
201.46MSharesUpdated Oct 27, 2026
Float Shares
195.35MSharesUpdated Oct 27, 2026
Shares Short
17.58MSharesUpdated Oct 27, 2026
Short Ratio
10.54days
vs all stocks
Updated Oct 27, 2026
Short % of Shares Outstanding
8.98%
vs all stocks
Updated Oct 27, 2026
% Held by Insiders
3.61%
vs all stocks
Updated Oct 27, 2026
% Held by Institutions
73.06%
vs all stocks
Updated Oct 27, 2026
Total Cash (MRQ)
56.26MUSD
vs all stocks (USD)
Updated Oct 27, 2026
Total Cash per Share (MRQ)
0.2790USDUpdated Oct 27, 2026
Total Debt (MRQ)
76.80MUSD
vs all stocks (USD)
Updated Oct 27, 2026
Total Debt to Equity (MRQ)
1.09x
vs Medical Devices peers
Updated Oct 27, 2026
Current Ratio (MRQ)
1.83x
vs Medical Devices peers
Updated Oct 27, 2026
Book Value per Share (MRQ)
0.3480USDUpdated Oct 27, 2026
Total Assets
221.86MUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
174.38MUSDFY2025 · Dec 31, 2025
Total Liabilities
156.89MUSDFY2025 · Dec 31, 2025
Total Non-current Assets
47.48MUSDFY2025 · Dec 31, 2025
Total Non-current Liabilities
56.09MUSDFY2025 · Dec 31, 2025
Total Current Liabilities
100.80MUSDFY2025 · Dec 31, 2025
Cash & Cash Equivalents
19.96MUSDFY2025 · Dec 31, 2025
Other Short-term Investments
62.92MUSDFY2025 · Dec 31, 2025
Accounts Receivable
30.37MUSDFY2025 · Dec 31, 2025
Inventory
56.10MUSDFY2025 · Dec 31, 2025
Accounts Payable
28.01MUSDFY2025 · Dec 31, 2025
Short-term Debt
46.25MUSDFY2025 · Dec 31, 2025
Deferred Revenue
1.27MUSDFY2025 · Dec 31, 2025
Long-term Debt
50.70MUSDFY2025 · Dec 31, 2025
Other Non-current Liabilities
5.39MUSDFY2025 · Dec 31, 2025
Common Stock (Book)
192.00KUSDFY2025 · Dec 31, 2025
Retained Earnings
-1.08BUSDFY2025 · Dec 31, 2025
Total Shareholders' Equity
64.97MUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
1.38USDUpdated Oct 27, 2026
52-Week High
3.47USDUpdated Oct 27, 2026
52-Week Change
58.00%
vs all stocks
Updated Oct 27, 2026
Beta
1.83x
vs all stocks
Updated Oct 27, 2026
50-Day MA
2.52USDUpdated Oct 27, 2026
200-Day MA
2.45USDUpdated Oct 27, 2026
Avg 10-Day Volume
1.94MSharesUpdated Oct 27, 2026
Avg 30-Day Volume
1.91MSharesUpdated Oct 27, 2026
Diluted EPS (TTM)
-0.0300USDUpdated Oct 27, 2026
Other Income / Expense
1.74MUSDFY2025 · Dec 31, 2025
3 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Debt is a large share of its assets, and large against its cash flow.
Reads
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
Elevated Leverage on Three Denominators
Debt sits high against its equity, its assets, and its cash flow.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.51Profit Margin: -0.03
Looks liquid, but the distress score says otherwiseNotable
Elevated Leverage on Three DenominatorsUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedWithin or Near the Altman Distress Zone
Elevated Leverage on Three DenominatorsUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedWithin or Near the Altman Distress Zone
Elevated Leverage on Three DenominatorsUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedWithin or Near the Altman Distress Zone